Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Best of the Blog: Personalized Medicine vs. Comparative Effectiveness

This article was originally published in RPM Report

Executive Summary

Readers of The IN VIVO Blog and The RPM Report's First Take responded to a post on whether proponents of personalized medicine can also be supporters of comparative effectiveness research. We asked readers to weigh in on that question. Their emails initiated a lively discussion on the future of health care so we've picked excerpts from the most noteworthy responses to share.

You may also be interested in...



Can Personalized Medicine and Comparative Effectiveness Coexist? The Experts Weigh In

Government, academic and industry experts comment on the potential for personalized medicine and comparative effectiveness research to support each other--and the consequences if they don't.

"Wise Policy" Needed To Link Comparative Effectiveness with Individualized Medicine

As comparative effectiveness matures from a political rallying cry and budget strategy to a process that the medical community will have to face as a new force with more financial and public support, the most thoughtful people in medicine are trying to find a way to understand the term and how it fits into other trends. It's not easy, even for them.

Personalized Medicine Offers Key To Creating Value In A Reformed Health Care System – HHS Secretary Leavitt

Personalized medicine holds much more potential than a mere niche area or a “series of new tests,” HHS official says at Boston conference.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS080420

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel